Studies indicate that the number of dementia cases in the United States is expected to double by 2060. A new study published ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ...

GLP-1 RAs, semaglutide and tirzepatide, significantly lower dementia, stroke, and all-cause mortality risks in T2D and obesity patients compared to other antidiabetic drugs. The study included 60,860 ...